A rise in NA-specific FcγRIIIa and FcγRIIa binding was detected following treatment with Flu-IVIG in B/Yamagata-infected patients (Supplemental Figure 4), which closely mirrored data for influenza HA. This evidence concerns the gene FCGR3A and influenza.